Global Tuberculosis Diagnostics Market Report 2020-2025: Increasing Prevalence of Multi-Drug Resistant (MDR) Tuberculosis is Driving Market Growth – ResearchAndMarkets.com

Global Tuberculosis Diagnostics Market Report 2020-2025: Increasing Prevalence of Multi-Drug Resistant (MDR) Tuberculosis is Driving Market Growth – ResearchAndMarkets.com




Global Tuberculosis Diagnostics Market Report 2020-2025: Increasing Prevalence of Multi-Drug Resistant (MDR) Tuberculosis is Driving Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The global tuberculosis diagnostics market is currently witnessing strong growth. The market to register a CAGR of around 3% during 2020-2025.

Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs.

In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB.

Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques.

Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor.

Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.

Key Questions Answered in this Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Tuberculosis Diagnostics Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Disease Stage

6.1 Latent TB

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Active TB

7 Market Breakup by Test Type

7.1 Radiographic Test

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Laboratory Test

7.2.1 Market Trends

7.2.2 Major Types

7.2.2.1 Smear Microscopy

7.2.2.2 Culture-based Test

7.2.3 Market Forecast

7.3 Nucleic Acid Testing

7.4 Cytokine Detection Test

7.5 Drug Resistance Test

7.6 Others

8 Market Breakup by End-User

8.1 Hospitals and Clinics

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Diagnostics and Research Laboratories

8.3 Others

9 Market Breakup by Region

10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

  • Abbott Laboratories
  • Alere Inc.
  • Becton Dickinson and Company
  • BioMerieux
  • Cepheid Inc.
  • Epistem Ltd.
  • Roche Holding AG
  • Hain Lifescience GmbH
  • Hologic Inc.
  • QIAGEN GmbH
  • Siemens
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/tzo6dh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900